Aubrey King
Child & Adolescent Psychiatry · Fresno, CANPI 1669577896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,094 and has fallen 73.0% since, to $296 in 2023. Among child & adolescent psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$596
- Johnson & Johnson$504
- Alkermes, Inc.$448
- Neurocrine Biosciences, Inc.$379
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$200
- Sunovion Pharmaceuticals Inc.$144
- plus $514 from 9 others
What the payments were for
- Food & beverage$2,73998%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 36 | $596 |
| Johnson & Johnson | 30 | $504 |
| Alkermes, Inc. | 20 | $448 |
| Neurocrine Biosciences, Inc. | 4 | $379 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $200 |
| Sunovion Pharmaceuticals Inc. | 11 | $144 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| Supernus Pharmaceuticals, Inc. | 7 | $97 |
| Indivior Inc. | 4 | $79 |
| Ironshore Pharmaceuticals Inc. | 4 | $76 |
| AbbVie(2 entities) | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Eisai Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,786 in reported general payments places this provider in the 90th percentile of 434 child & adolescent psychiatry providers in California.
See all child & adolescent psychiatry providers in California →
Other child & adolescent psychiatry in Fresno
- Sukhjit BrarFresno$283K
- Nirmal BrarFresno$12K
- Indira AdapaFresno$7K
- Kevin CoxOjai$2.9M
- Manpreet SinghSacramento$104K
- Ihab SolimanCorona del Mar$93K
- Syed NaqviLos Angeles$69K
- Ellen HeynemanSan Diego$62K
- Mark McDonaldLos Angeles$31K
- James HartmanDanville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.